Orchestra BioMed Holdings, Inc. Adjustments to Additional Paid in Capital, Other
Orchestra BioMed Holdings, Inc. (OBIO) reported Adjustments to Additional Paid in Capital, Other of $506.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-27.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2024-03-27
- Orchestra BioMed Holdings, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-06-30 was $506.00K.
- Orchestra BioMed Holdings, Inc. adjustments to additional paid in capital, other for fiscal 2022 was $506.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2022-12-31 | $506.00K 10-K · filed 2024-03-27 | |
| 2022-06-30 | $506.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |